BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6712065)

  • 1. Ocular fluorophotometry in diabetic patients without apparent retinopathy.
    Kayazawa F
    Ann Ophthalmol; 1984 Mar; 16(3):221-5. PubMed ID: 6712065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous fluorophotometric evaluation of diabetics.
    Bursell SE; Delori FC; Yoshida A; Parker JS; Collas GD; McMeel JW
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular fluorophotometry using high S-N ratio fluorophotometer.
    Kayazawa F
    Ann Ophthalmol; 1984 May; 16(5):472-6. PubMed ID: 6742687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous fluorophotometry: identification of sources of variability.
    Prager TC; Wilson DJ; Avery GD; Merritt JH; Garcia CA; Hopen G; Anderson RE
    Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):854-64. PubMed ID: 7309436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic vitreous fluorophotometry in normals and noninsulin-dependent diabetics.
    Cunha-Vaz JG; Zeimer R; Wong WP; Kiani R
    Ophthalmology; 1982 Jul; 89(7):751-6. PubMed ID: 7122051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the crystalline lens by fluorophotometry in 60 control subjects and 56 diabetics].
    Bordat B; Laudeho A; Guirguis IR; Arnaud C
    J Fr Ophtalmol; 1992; 15(2):113-8. PubMed ID: 1640064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
    Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
    J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular fluorophotometric analysis.
    Mosier MA; Gray JR; Ishimoto BM
    Curr Eye Res; 1982-1983; 2(10):699-704. PubMed ID: 7186436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with fluorophotometry.
    Brooks AM
    Aust J Ophthalmol; 1982 Feb; 10(1):41-51. PubMed ID: 7103862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluorophotometry of changes of hemato-ocular barriers in intermediate uveitis].
    Baglivo E; Bloch-Michel E; Ducot B; Offret M; Offret H
    J Fr Ophtalmol; 1995; 18(6-7):421-5. PubMed ID: 7560782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biometric investigation of ocular components in amblyopia.
    Cass K; Tromans C
    Ophthalmic Physiol Opt; 2008 Sep; 28(5):429-40. PubMed ID: 18761480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of early retinal changes in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Diabetes; 1979 Jan; 28(1):16-9. PubMed ID: 759246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.
    Cunha-Vaz JG; Gray JR; Zeimer RC; Mota MC; Ishimoto BM; Leite E
    Diabetes; 1985 Jan; 34(1):53-9. PubMed ID: 3964755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between autofluorescence and advanced glycation end products in diabetic lenses.
    Abiko T; Abiko A; Ishiko S; Takeda M; Horiuchi S; Yoshida A
    Exp Eye Res; 1999 Mar; 68(3):361-6. PubMed ID: 10079144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.